• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » OrthoPediatrics buys Pega Medical for up to $33M

OrthoPediatrics buys Pega Medical for up to $33M

June 14, 2022 By Chris Newmarker

Promo image of the Pega Medical Fassier-Duval Telescopic Intramedullary System getting acquired by OrthoPediatrics
The Fassier-Duval Telescopic Intramedullary System is a self-extending rod meant to prevent or stabilize fractures or correct deformity of long bones while growth occurs. [Image courtesy of Pega Medical]
OrthoPediatrics announced today that it has agreed to acquire Pega Medical and its Fassier-Duval Telescopic Intramedullary System for osteogenesis imperfecta and other bone deformities.

“Similar to OrthoPediatrics, the Pega organization has been focused exclusively on addressing unmet needs for children whose lives have been impacted by musculoskeletal disorders and diseases. Their product offerings include novel technologies to treat some of the most unique conditions in pediatric orthopedics,” OrthoPediatrics CEO David Bailey said in a news release.

Warsaw, Indiana–based OrthoPediatrics will buy Pega Medical for an upfront cash payment of $31 million — as well as $2 million in stock that includes certain restrictions for three years. To help finance the transaction, OrthoPediatrics has successfully increased its line of credit with Squadron Capital from $25 million to $50 million.

Also today, OrthoPediatrics increased its full-year 2022 revenue guidance range to $125 million–128 million, a 27– 31% increase. On an organic basis, excluding Pega Medical and the recently acquired MD Orthopaedics, OrthoPediatrics is reiterating its full-year revenue guidance range of $118–121 million, representing 20–23% growth.

Analysts were mostly positive about the news. BTIG analyst Ryan Zimmerman thought the sales price is fair, with Pega bringing in $6 million in annual revenue.

We further believe the acquisition of Pega serves not just to bolster growth but as a defensive acquisition that prevents others in the space from gaining scale,” Zimmerman said. “We always believed Pega would make for an acquisition candidate for anyone looking to establish a presence in pediatric orthopedics. KIDS benefits by blocking others from gaining a foothold and can run Pega’s products through its massive sales infrastructure.

Truist analysts described the purchase as “another interesting deal that deepens KIDS’ moat as the specialist in pediatric orthopedics and adds an interesting growth driver to the company’s portfolio.”

KIDS shares were down more than 1% to $39.88 by midday trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was down slightly.

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, News Well, Orthopedics, Pediatrics

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy